Lexington Biosciences Inc. (LXGTF)

[Greenleaf1]

Oh, I based that off of $500K. But with paid promoters way back when, lxgtf has seen just under $.42. It slowly went down to .05 for a short time, settling to where its at now. It moves on news. Its hard to do a valuation, but there are very limited shares with this stock compared to others. There should be news with trial completion, raising the price, I think $2 after fda approval is reasonable. With paid promoters, more, but it makes me nervous to sell, because we all know what eventually happens there.